ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Mitsubishi Chemical Holdings has agreed to pay about $640 million for Qualicaps, a Japan-based producer of gelatin and cellulose capsules for drug and nutritional products. The seller is the private equity firm Carlyle Group, which acquired Qualicaps from the Japanese drug firm Shionogi in 2005. The parties expect Qualicaps to post 2012 sales of about $220 million. Mitsubishi says Qualicaps will complement its active pharmaceutical ingredients business. Mitsubishi also expects to apply its own know-how in resin processing and cellulose-based materials.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter